Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
25 July 2018
Ebola vaccine praised as Congo outbreak declared over
7 June 2018
Gavi Board appoints Bill Roedy as Vice Chair
23 May 2018
Gavi's response to the DRC Ebola outbreak
21 May 2018
Ebola vaccine to help tackle DRC outbreak
19 May 2018
Gavi welcomes call for coordinated global action against cervical cancer
Immunisation at the 71st World Health Assembly
3 April 2018
New typhoid vaccine to receive Gavi support
23 March 2018
U.S. approves $290 million for Gavi in fiscal year 2018 appropriations omnibus
8 March 2018
Gavi named amongst highest scorers in gender equality report
7 February 2018
South Sudan cholera outbreak ends
4 January 2018
Gavi welcomes new UNICEF executive director
29 November 2017
Gavi and its representatives awarded Medals of labour by Lao PDR president